nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—SHBG—Spironolactone—dilated cardiomyopathy	0.521	0.58	CbGbCtD
Estriol—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.239	0.266	CbGbCtD
Estriol—ABCB1—Lisinopril—dilated cardiomyopathy	0.0733	0.0817	CbGbCtD
Estriol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0645	0.0719	CbGbCtD
Estriol—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00849	0.0927	CcSEcCtD
Estriol—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0056	0.0611	CcSEcCtD
Estriol—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00478	0.0522	CcSEcCtD
Estriol—Breast pain—Spironolactone—dilated cardiomyopathy	0.00355	0.0388	CcSEcCtD
Estriol—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00354	0.0387	CcSEcCtD
Estriol—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00285	0.0311	CcSEcCtD
Estriol—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00155	0.0169	CcSEcCtD
Estriol—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00147	0.0161	CcSEcCtD
Estriol—Breast pain—Lisinopril—dilated cardiomyopathy	0.00145	0.0158	CcSEcCtD
Estriol—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00141	0.0154	CcSEcCtD
Estriol—Alopecia—Spironolactone—dilated cardiomyopathy	0.00137	0.015	CcSEcCtD
Estriol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00137	0.0149	CcSEcCtD
Estriol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0013	0.0142	CcSEcCtD
Estriol—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00126	0.0138	CcSEcCtD
Estriol—Fluid retention—Lisinopril—dilated cardiomyopathy	0.0012	0.0131	CcSEcCtD
Estriol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00111	0.0121	CcSEcCtD
Estriol—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00106	0.0116	CcSEcCtD
Estriol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00099	0.0108	CcSEcCtD
Estriol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000954	0.0104	CcSEcCtD
Estriol—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000937	0.0102	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.00092	0.0806	CbGpPWpGaD
Estriol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000911	0.00994	CcSEcCtD
Estriol—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000892	0.00974	CcSEcCtD
Estriol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000878	0.00959	CcSEcCtD
Estriol—ESR2—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000836	0.0733	CbGpPWpGaD
Estriol—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00083	0.00906	CcSEcCtD
Estriol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000816	0.00891	CcSEcCtD
Estriol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000814	0.00889	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.000805	0.0705	CbGpPWpGaD
Estriol—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0008	0.00874	CcSEcCtD
Estriol—Asthma—Lisinopril—dilated cardiomyopathy	0.000793	0.00866	CcSEcCtD
Estriol—Eye disorder—Furosemide—dilated cardiomyopathy	0.000791	0.00864	CcSEcCtD
Estriol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000782	0.00854	CcSEcCtD
Estriol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000768	0.00839	CcSEcCtD
Estriol—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000765	0.00835	CcSEcCtD
Estriol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000756	0.00826	CcSEcCtD
Estriol—Malnutrition—Furosemide—dilated cardiomyopathy	0.000737	0.00805	CcSEcCtD
Estriol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000731	0.00798	CcSEcCtD
Estriol—Flatulence—Furosemide—dilated cardiomyopathy	0.000726	0.00793	CcSEcCtD
Estriol—Weight increased—Lisinopril—dilated cardiomyopathy	0.000722	0.00788	CcSEcCtD
Estriol—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000718	0.00784	CcSEcCtD
Estriol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000708	0.00774	CcSEcCtD
Estriol—Depression—Lisinopril—dilated cardiomyopathy	0.000705	0.0077	CcSEcCtD
Estriol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000703	0.00767	CcSEcCtD
Estriol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000697	0.00761	CcSEcCtD
Estriol—Rash—Spironolactone—dilated cardiomyopathy	0.000697	0.00761	CcSEcCtD
Estriol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000696	0.0076	CcSEcCtD
Estriol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000693	0.00757	CcSEcCtD
Estriol—Headache—Spironolactone—dilated cardiomyopathy	0.000692	0.00756	CcSEcCtD
Estriol—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000669	0.00731	CcSEcCtD
Estriol—Nausea—Spironolactone—dilated cardiomyopathy	0.000657	0.00717	CcSEcCtD
Estriol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000626	0.00683	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000623	0.0068	CcSEcCtD
Estriol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000601	0.00657	CcSEcCtD
Estriol—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.0006	0.00656	CcSEcCtD
Estriol—Shock—Furosemide—dilated cardiomyopathy	0.000592	0.00646	CcSEcCtD
Estriol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00059	0.00644	CcSEcCtD
Estriol—Skin disorder—Furosemide—dilated cardiomyopathy	0.000584	0.00638	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.000579	0.0507	CbGpPWpGaD
Estriol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000576	0.00629	CcSEcCtD
Estriol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000561	0.00613	CcSEcCtD
Estriol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000556	0.00608	CcSEcCtD
Estriol—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000553	0.00604	CcSEcCtD
Estriol—Flatulence—Lisinopril—dilated cardiomyopathy	0.000545	0.00595	CcSEcCtD
Estriol—Tension—Lisinopril—dilated cardiomyopathy	0.000543	0.00592	CcSEcCtD
Estriol—Nervousness—Lisinopril—dilated cardiomyopathy	0.000537	0.00586	CcSEcCtD
Estriol—Back pain—Lisinopril—dilated cardiomyopathy	0.000535	0.00584	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.000534	0.0468	CbGpPWpGaD
Estriol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000532	0.0058	CcSEcCtD
Estriol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000519	0.00567	CcSEcCtD
Estriol—Pain—Furosemide—dilated cardiomyopathy	0.000514	0.00562	CcSEcCtD
Estriol—Angioedema—Lisinopril—dilated cardiomyopathy	0.000505	0.00552	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000493	0.0432	CbGpPWpGaD
Estriol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000492	0.00537	CcSEcCtD
Estriol—Urticaria—Furosemide—dilated cardiomyopathy	0.000478	0.00522	CcSEcCtD
Estriol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000475	0.00519	CcSEcCtD
Estriol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000469	0.00512	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000467	0.0051	CcSEcCtD
Estriol—Oedema—Lisinopril—dilated cardiomyopathy	0.000451	0.00493	CcSEcCtD
Estriol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000451	0.00493	CcSEcCtD
Estriol—Infection—Lisinopril—dilated cardiomyopathy	0.000448	0.00489	CcSEcCtD
Estriol—Shock—Lisinopril—dilated cardiomyopathy	0.000444	0.00485	CcSEcCtD
Estriol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000443	0.00484	CcSEcCtD
Estriol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000438	0.00479	CcSEcCtD
Estriol—Pruritus—Furosemide—dilated cardiomyopathy	0.000425	0.00465	CcSEcCtD
Estriol—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000421	0.0369	CbGpPWpGaD
Estriol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000411	0.00449	CcSEcCtD
Estriol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000408	0.00446	CcSEcCtD
Estriol—Dizziness—Furosemide—dilated cardiomyopathy	0.000398	0.00434	CcSEcCtD
Estriol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000397	0.00434	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000395	0.0346	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00039	0.00425	CcSEcCtD
Estriol—Pain—Lisinopril—dilated cardiomyopathy	0.000386	0.00421	CcSEcCtD
Estriol—Vomiting—Furosemide—dilated cardiomyopathy	0.000382	0.00417	CcSEcCtD
Estriol—Rash—Furosemide—dilated cardiomyopathy	0.000379	0.00414	CcSEcCtD
Estriol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000379	0.00414	CcSEcCtD
Estriol—Headache—Furosemide—dilated cardiomyopathy	0.000377	0.00411	CcSEcCtD
Estriol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000369	0.00403	CcSEcCtD
Estriol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000358	0.00391	CcSEcCtD
Estriol—Nausea—Furosemide—dilated cardiomyopathy	0.000357	0.0039	CcSEcCtD
Estriol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000357	0.00389	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000351	0.0308	CbGpPWpGaD
Estriol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000332	0.00363	CcSEcCtD
Estriol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000319	0.00349	CcSEcCtD
Estriol—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000318	0.0278	CbGpPWpGaD
Estriol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000309	0.00337	CcSEcCtD
Estriol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000298	0.00326	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000294	0.0258	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000291	0.0255	CbGpPWpGaD
Estriol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000287	0.00313	CcSEcCtD
Estriol—Rash—Lisinopril—dilated cardiomyopathy	0.000284	0.00311	CcSEcCtD
Estriol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000284	0.0031	CcSEcCtD
Estriol—Headache—Lisinopril—dilated cardiomyopathy	0.000283	0.00309	CcSEcCtD
Estriol—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000274	0.024	CbGpPWpGaD
Estriol—Nausea—Lisinopril—dilated cardiomyopathy	0.000268	0.00293	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000205	0.018	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000149	0.013	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000147	0.0128	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000144	0.0127	CbGpPWpGaD
Estriol—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000142	0.0124	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000137	0.012	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000131	0.0115	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000119	0.0104	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.000114	0.00998	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	0.000113	0.00993	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000109	0.00956	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000107	0.00938	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000105	0.00918	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000103	0.00899	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000101	0.00888	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	9.56e-05	0.00838	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	9.47e-05	0.0083	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	9.4e-05	0.00824	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	9.28e-05	0.00814	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	9.07e-05	0.00795	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.07e-05	0.00795	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.89e-05	0.00779	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	7.75e-05	0.0068	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.39e-05	0.00648	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	7.28e-05	0.00638	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.19e-05	0.0063	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.19e-05	0.0063	CbGpPWpGaD
Estriol—ESR2—Gene Expression—NR3C2—dilated cardiomyopathy	6.95e-05	0.00609	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.69e-05	0.00586	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	6.52e-05	0.00572	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	6.37e-05	0.00558	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	6.28e-05	0.0055	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	6.06e-05	0.00531	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.89e-05	0.00517	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	5.47e-05	0.00479	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	5.41e-05	0.00474	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	5.08e-05	0.00446	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.9e-05	0.0043	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	4.86e-05	0.00426	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.74e-05	0.00416	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	4.66e-05	0.00408	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	4.57e-05	0.00401	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.57e-05	0.00401	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	4.57e-05	0.004	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	4.53e-05	0.00397	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.48e-05	0.00393	CbGpPWpGaD
Estriol—ESR2—Gene Expression—NPPA—dilated cardiomyopathy	4.36e-05	0.00383	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	4.13e-05	0.00362	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.04e-05	0.00354	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.85e-05	0.00337	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	3.57e-05	0.00313	CbGpPWpGaD
Estriol—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	3.5e-05	0.00307	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.16e-05	0.00277	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.08e-05	0.0027	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.08e-05	0.0027	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.97e-05	0.0026	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.86e-05	0.00251	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.52e-05	0.00221	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.51e-05	0.0022	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	2.46e-05	0.00216	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.45e-05	0.00215	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	2.45e-05	0.00214	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.42e-05	0.00212	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.37e-05	0.00208	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.21e-05	0.00194	CbGpPWpGaD
Estriol—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	2.2e-05	0.00193	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.08e-05	0.00182	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.08e-05	0.00182	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.04e-05	0.00179	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.96e-05	0.00171	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.94e-05	0.0017	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.77e-05	0.00155	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.57e-05	0.00138	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.46e-05	0.00128	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.39e-05	0.00121	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.23e-05	0.00108	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.23e-05	0.00108	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.14e-05	0.001	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.12e-05	0.000984	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.11e-05	0.000971	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	0.000958	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.08e-05	0.000945	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.03e-05	0.0009	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	9.84e-06	0.000863	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.46e-06	0.000829	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.98e-06	0.000787	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.71e-06	0.000676	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.97e-06	0.000611	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	6.66e-06	0.000584	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.24e-06	0.000547	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.81e-06	0.000421	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.68e-06	0.00041	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.62e-06	0.000405	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.21e-06	0.000369	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.17e-06	0.000278	CbGpPWpGaD
